• National Fuel Gas Company recently reported third-quarter 2026 results, reaffirmed its 2026 production guidance of 420–430 Bcf, and confirmed completion of a US$118.29 million share repurchase program initiated in March 2024.
• Together with progress toward closing its acquisition of CenterPoint’s Ohio gas utilities and an updated long-term earnings outlook through 2029, these developments highlight management’s focus on regulated growth, production efficiency and disciplined capital returns.
• Next, we’ll examine how the updated long-term earnings outlook through 2029 could reshape National Fuel Gas’s existing investment narrative.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 28 best rare earth metal stocks of the very few that mine this essential strategic resource.

National Fuel Gas Investment Narrative Recap

To own National Fuel Gas, you have to be comfortable with a story built around regulated utility growth, Appalachian gas production and steady capital returns. The latest earnings, updated 2026 production guidance of 420–430 Bcf and completion of the US$118.29 million buyback do not materially change the near term focus on closing the Ohio gas utilities acquisition as the key catalyst, or on policy driven decarbonization and electrification trends as the biggest long term risk.

Among the recent announcements, the updated long term earnings outlook through 2029, with management targeting 7% to 10% annual EPS growth supported by regulated businesses and upstream efficiencies, is most relevant. It sits alongside the production guidance reset and Ohio acquisition progress as a core part of how investors might weigh the potential benefits of regulated expansion against rising capital needs for system modernization and possible pressure from energy transition policies.

Yet while growth plans look clear, investors should be aware of how faster decarbonization policies could leave parts of the gas network at risk of becoming...

National Fuel Gas' narrative projects $3.3 billion revenue and $790.4 million earnings by 2029. This requires 9.2% yearly revenue growth and an earnings increase of about $115 million from $675.3 million today.

Uncover how National Fuel Gas' forecasts yield a $98.50 fair value, a 22% upside to its current price.

Exploring Other Perspectives

Three Simply Wall St Community fair value estimates span roughly US$46.65 to US$112.69, showing how far apart individual views can be. When you set these against the company’s emphasis on regulated growth and efficiency gains through 2029, it underlines how differently people weigh long term policy and electrification risks for National Fuel Gas.

Explore 3 other fair value estimates on National Fuel Gas - why the stock might be worth as much as 40% more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your National Fuel Gas research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free National Fuel Gas research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate National Fuel Gas' overall financial health at a glance.

Searching For A Fresh Perspective?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Find 52 companies with promising cash flow potential yet trading below their fair value.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.